Richards Group (RIC) Q4 2024 earnings summary

Executive summary

• Revenue declined 4.3% year-over-year, mainly due to a 13.5% drop in food & beverage and lower healthcare capital sales, partially offset by stable cosmetics and positive currency translation.

• Adjusted EBITDA decreased by $1.1 million, but margin improved to 14% of sales, reflecting higher gross profit margins offset by increased administrative expenses and FX losses.

• Net income fell by $3 million, or $0.13 per Unit, due to lower Adjusted EBITDA, a reduced mark-to-market gain on exchangeable shares, exceptional items, and contingent consideration revaluation.

• Acquisitions of Insight (June 2024), National Dental, and HL Production SA (February 2025) are expected to restore revenue growth in 2025.

Financial highlights

• Revenue: $407.8 million (down from $425.9 million in 2023).

• Adjusted EBITDA: $56.9 million (14% of sales), down $1.1 million year-over-year.

• Net income: $35.8 million, down from $38.9 million in 2023.

• Free cash flow: $24.4 million, up from $22.2 million in 2023.

• Distributable cash flow per Unit: $3.46, payout ratio 38%.

• Regular distributions: $1.32 per Unit (11¢ monthly), special distribution: 36¢ per Unit.

• Debt fully repaid; leverage ratio reduced to nil.

Outlook and guidance

• Core revenue growth targeted at 2% to 5% for 2025, assuming stable economic conditions.

• Acquisitions expected to contribute $1.4 million in Q1 2025 revenue.

• Maintenance capital for 2025 projected at $1.5 million, funded by free cash flow.

• No special distribution planned for 2025 to prioritize funding for acquisitions.